RBC Capital Maintains Outperform on Alkermes, Raises Price Target to $57

Benzinga · 5d ago
RBC Capital analyst Leonid Timashev maintains Alkermes (NASDAQ:ALKS) with a Outperform and raises the price target from $56 to $57.